Delivery Order V797D40076-VA24616F3187

This definitive contract awarded to Allosource, a non-profit manufacturer of human tissue allografts, provides $12,497,381.00 in funding from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of allograft skin products to support emergency burn mass casualty response capabilities nationwide through September 2032. This contract award stems from a prior Sources Sought notice issued by HHS in...

This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Allosource, a non-profit organization and manufacturer of goods, for the provision of various allograft tissue and bones. The contract has a ceiling value of $134,576.46 and a period of performance through September 30, 2016. Allosource is a prime contractor and has not been awarded this contract under any set-aside designation. The company has received over $12 million in federal contracts...

This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Allosource, a non-profit organization and manufacturer of goods. The contract, valued at $179,593.00, is for the provision of various surgical grafts. Allosource has been awarded multiple federal contracts from the Department of Health and Human Services, Department of Veterans Affairs, and Department of the Air Force Materiel Command to provide human tissue allografts, surgical implants,...

This federal contract award, identified as W91YU014A0010|0007, was granted by the Medical Command (MEDCOM) component of the U.S. Department of Defense. The $93,350.00 Firm Fixed Price contract is for the provision of "VARIOUS ALLOGRAFT BONE AND TISSUE" and was awarded to Lifecell Corporation, a division of Allergan, Inc. The contract has no set-aside designation and is for a period ending on September 30, 2016. This appears to be a Blanket Purchase Agreement (BPA) call, which is a type...

This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Allosource, a non-profit organization and manufacturer of goods, for the provision of various surgical grafts. The contract has a potential value of $103,150.00 and a completion date of September 30, 2020. Allosource is a provider of human tissue allografts for surgical procedures and burn care, and has received over $12 million in federal contracts from the Department of Health and Human...

This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Applied Biologics LLC, a veteran-owned limited liability company. The contract is for the delivery of "#FTG-10400 ALLOGRAFT, FLOWGRAFT (3)" with a ceiling value of $9,225.00 and an ultimate completion date of June 8, 2016. The contract was awarded on May 26, 2016 and did not utilize any set-aside designation. No additional subcontractor information was provided.

Biomet 3I LLC, doing business as 3I Implant Innovations, has been awarded a $1,576 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide ALLOGRAFT PUROS 1S biomaterials. The delivery order was awarded on June 16, 2021 under the DLA's indefinite-delivery/indefinite-quantity contracts for medical equipment and supplies, with performance at the contractor's facility in Riviera Beach, Florida and a completion date of June 22, 2021. No set-aside...

Arthrex Inc. has been awarded a delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide allograft graft material. The $12,549.60 fixed-price with economic price adjustment contract calls for the delivery of one 10.5mm diameter by 69mm long allograft graft to Naples, Florida by August 1, 2023. The Defense Logistics Agency Troop Support Medical supports the medical supply needs of the Department of Defense and this...

<p>This is a federal contract award issued by the U.S. Army Medical Command (MEDCOM) to Lifecell Corporation, a subsidiary of Allergan, Inc. The contract is for the provision of various allograft bone and tissue products, with a ceiling value of $91,733.00. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. The period of performance is through September 30, 2017. This contract award does not have a set-aside designation.</p>

This federal contract award to Transplant Technology Inc., operating as Bone Bank Allografts, is for the provision of surgical implants to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $11,000.00, firm fixed-price purchase order has an ultimate completion date of October 2, 2023. Transplant Technology Inc. is a for-profit manufacturer of goods that specializes in providing surgical implants and bone allograft products to support various medical...